Unusual suspect for antipsychotic-induced diabetes.
O'Neill
Michael F
MF
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D006801:Humans; D000077152:Olanzapine; D043587:Receptor, Muscarinic M3 / Q000037:antagonists & inhibitors / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy; D015430:Weight Gain / Q000187:drug effects / Q000502:physiology
D014150:Antipsychotic Agents; D043587:Receptor, Muscarinic M3; D001569:Benzodiazepines; D000077152:Olanzapine